AKT2-Related Disorders: A Patient Guide
At a Glance
AKT2-related disorders are rare genetic conditions that disrupt fat storage and insulin signaling. Depending on the variant, they can cause insulin resistance, diabetes and high triglycerides, or episodes of low blood sugar, so care is individualized.
AKT2-related Familial Partial Lipodystrophy (FPLD) and other AKT2-related disorders are exceptionally rare genetic conditions that fundamentally change how your body manages energy. In most people, the body stores excess energy as fat in a soft layer just under the skin of the arms, legs, and trunk. In people with this condition, a “spelling error” in the AKT2 gene disrupts this process, making it difficult or impossible for the body to store fat in these traditional “warehouses.” Instead of being tucked away safely, fat and fatty acids often stay in the blood or “spill over” into internal organs like the liver and muscles, where they can cause significant health challenges [1][2].
Because this condition is exceptionally rare, much of the management guidance is extrapolated from broader lipodystrophy cohorts, and your specific experience will depend heavily on your exact genetic variant. A pathogenic change to the gene leads to extreme clinical variability.
The AKT2 gene acts as a critical master switch for insulin signaling, the process that tells your cells to take up sugar from the blood or store fat. Because this switch is at the center of your metabolism, any change to it can lead to extreme clinical variability. For some, the switch is partially “off,” leading to severe insulin resistance, early-onset diabetes, and dangerously high levels of blood fats (triglycerides). For others, a different variant might turn the switch “on” permanently, causing the body to act as if insulin is always present, which can result in episodes of dangerously low blood sugar (hypoglycemia) [3][4].
Living with this condition requires a proactive approach focused on three key pillars: recognizing your body’s unique physical pattern, managing the metabolic consequences of energy spillover, and building a specialized care team. Because AKT2-related disease is so rare, your physical signs—such as a muscular appearance in the limbs or fat accumulation around the neck—are important clues that help doctors tailor your treatment. Protecting your heart and liver from the effects of high triglycerides and blood sugar is the primary goal of long-term care [5][6].
Ultimately, an AKT2 diagnosis is not a one-size-fits-all condition, and your experience will depend heavily on your specific genetic variant. By working with a multidisciplinary team of specialists—including endocrinologists, geneticists, and dietitians—you can create a management plan that protects your metabolic health. Understanding the “broken switch” in your insulin pathway is the first step toward navigating this rare diagnosis with confidence and clarity [6][7].
Note: Navigating a very rare disease, frequent appointments, and changes to your body shape can cause significant distress or body-image anxiety. It is completely normal to feel overwhelmed, and seeking support from a counselor or rare-disease patient group is an important part of your care.
In this guide
6 chapters
Understanding Your Diagnosis: AKT2-Related FPLD
Learn how AKT2-related FPLD affects fat distribution and blood sugar, plus monitoring and treatment for insulin resistance, low blood sugar, and liver health.
Signs, Symptoms, and the Road to Diagnosis
Learn how AKT2-related familial partial lipodystrophy causes fat loss, insulin resistance, and metabolic clues, plus scans and genetic testing for diagnosis.
Metabolic Complications: How AKT2 Affects Your Health
Learn how AKT2-related familial partial lipodystrophy affects blood sugar, triglycerides, liver health, reproductive health, and pancreatitis risk, plus key tests.
Standard of Care: Managing Your AKT2-Related FPLD
Learn how AKT2-related familial partial lipodystrophy is treated with nutrition, diabetes and triglyceride medicines, metreleptin, and safety guidance for care.
Staying Safe: Monitoring and Emergency Signs
Learn how AKT2-related FPLD is monitored, which emergency signs need urgent care, and how to plan for pancreatitis, DKA, low blood sugar, and pregnancy.
Building Your Care Team and Preparing for Visits
Learn how to build an AKT2-related familial partial lipodystrophy care team, prepare genetic and lab records, and coordinate specialist visits for ongoing care.
Common questions in this guide
What is AKT2-related familial partial lipodystrophy?
Why can AKT2 variants cause either high or low blood sugar?
What body changes can occur with AKT2-related disease?
What health problems should be monitored with AKT2-related disease?
Which specialists can help manage AKT2-related disorders?
Should family members have genetic testing for an AKT2 variant?
Questions to Ask Your Doctor
Curated prompts to bring to your next appointment.
- 1.What is my specific AKT2 variant, and does it cause a loss or gain of function in the insulin pathway?
- 2.Are my current metabolic levels—like triglycerides and blood sugar—in a range that requires immediate intervention?
- 3.Can you recommend an endocrinologist or a center of excellence with experience in rare monogenic insulin resistance?
- 4.What specific screening tests do I need to monitor my liver and heart health based on my symptoms?
- 5.How does my diagnosis affect the health and genetic screening recommendations for my close family members?
Questions For You
Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.
References
References (7)
- 1
Familial Partial Lipodystrophy (FPLD): Recent Insights.
Bagias C, Xiarchou A, Bargiota A, Tigas S
Diabetes, metabolic syndrome and obesity : targets and therapy 2020; (13()):1531-1544 doi:10.2147/DMSO.S206053.
PMID: 32440182 - 2
Dunnigan lipodystrophy syndrome: French National Diagnosis and Care Protocol (PNDS; Protocole National de Diagnostic et de Soins).
Mosbah H, Donadille B, Vatier C, et al.
Orphanet journal of rare diseases 2022; (17(Suppl 1)):170 doi:10.1186/s13023-022-02308-7.
PMID: 35440056 - 3
Treatment of hypoglycemia due to a rare pathogenic variant in AKT2 with waxy maize heat-modified starch.
Parker M, Yau D
Clinical case reports 2024; (12(2)):e8473 doi:10.1002/ccr3.8473.
PMID: 38344362 - 4
Constitutive Activation of AKT2 in Humans Leads to Hypoglycemia Without Fatty Liver or Metabolic Dyslipidemia.
Minic M, Rocha N, Harris J, et al.
The Journal of clinical endocrinology and metabolism 2017; (102(8)):2914-2921 doi:10.1210/jc.2017-00768.
PMID: 28541532 - 5
Lipodystrophy for the Diabetologist-What to Look For.
Patni N, Garg A
Current diabetes reports 2022; (22(9)):461-470 doi:10.1007/s11892-022-01485-w.
PMID: 35821558 - 6
The Diagnosis and Management of Lipodystrophy Syndromes: A Multi-Society Practice Guideline.
Brown RJ, Araujo-Vilar D, Cheung PT, et al.
The Journal of clinical endocrinology and metabolism 2016; (101(12)):4500-4511 doi:10.1210/jc.2016-2466.
PMID: 27710244 - 7
Diagnosis, treatment and management of lipodystrophy: the physician perspective on the patient journey.
Patni N, Chard C, Araújo-Vilar D, et al.
Orphanet journal of rare diseases 2024; (19(1)):263 doi:10.1186/s13023-024-03245-3.
PMID: 38992753
This page explains AKT2-related disorders for educational purposes only and does not replace medical advice. An endocrinologist and geneticist can help interpret your variant, metabolic results, and screening needs.
Get notified when new evidence is published on AKT2-related familial partial lipodystrophy.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.